Pharma Reviews: China's war on healthcare costs lures India's biggest drugmaker

The $160 billion Chinese drug market “is now a focus for Indian generics” as U.S.-approved drugs are cleared faster, Jefferies analyst Piyush Nahar ...
Read more: China's war on healthcare costs lures India's biggest drugmaker